FireFly Neuroscience Announces Healthcare Science and AI Industry Leader David DeCaprio to Join Board of Directors
17 Aprile 2024 - 2:30PM
Firefly Neuroscience, Inc. (“Firefly” or the “Company”), a
pioneering AI company developing innovative neuroscientific
solutions to improve outcomes for patients with mental illnesses
and neurological disorders, announces that Healthcare Science and
AI Industry leader, David DeCaprio (“DeCaprio”), has entered into
an agreement to join the Company’s Board of Directors upon
completion of the anticipated merger with WaveDancer, Inc.
(“WaveDancer”) (NASDAQ: WAVD). This appointment is a key step
towards Firefly’s anticipated start of trading on the NASDAQ.
DeCaprio has significant experience
transitioning advanced technology from academic research labs into
successful businesses. He is a Co-founder of ClosedLoop.ai, which
has been recognized as the #1 AI platform for healthcare from 2022
through 2024. Additionally, he was the winner of the CMS AI Health
Outcomes Challenge and was an Engineering Lead for the Human Genome
Project at the Broad Institute of MIT and Harvard.
“With the upcoming merger with WaveDancer and
subsequent listing on NASDAQ, we are entering a transformational
moment in the history of the Company,” said Jon Olsen, CEO of
Firefly. “We are honored to welcome Mr. DeCaprio to Firefly’s Board
of Directors, and we look forward to leveraging Mr. DeCaprio’s
breadth and depth of expertise as we continue to develop innovative
neuroscientific solutions to improve outcomes for patients with
mental illnesses and neurological disorders.”
About Firefly
Firefly is a medical technology and AI company
developing and pioneering innovative neuroscientific solutions that
improve outcomes for patients with mental illnesses and
neurological disorders. The Company has developed its FDA-510(k)
cleared Brain Network Analytics (“BNA”) software platform (the
“Platform”) and is focused on advancing diagnostic and treatment
approaches for people suffering from mental illnesses and cognitive
disorders, including depression, dementia, anxiety disorders,
concussions, and attention-deficit/hyperactivity disorder (ADHD).
Over the last 15 years the Company has invested approximately $60
million to develop its BNA software, compile a database of brain
wave tests, gain patent protection, and receive FDA approval to
market and sell the Platform. As a result, Firefly is now pursuing
commercial launch of the BNA Platform in multiple markets
including, pharmaceutical companies with drug research and clinical
trial activities and medical practitioners for use in their
clinics.
The BNA Platform is a software as a medical
solution (SAMS) that was developed using artificial intelligence
(AI) and machine learning (ML) on Firefly’s extensive proprietary
database of standardized, high-definition longitudinal
electroencephalograms (EEGs) of over 17,000 patients representing
twelve disorders, as well as clinically normal patients. The BNA
Platform, in conjunction with an FDA-cleared EEG system, can
provide clinicians with comprehensive insights into brain function
(cognition). These insights can enhance a clinician’s ability to
accurately diagnose mental illnesses and cognitive disorders and to
evaluate what therapy and/or drug is best suited to optimize a
patient’s outcome.
Please visit, https://fireflyneuro.com/, for
more information.
Forward-Looking Statements
Certain statements in this press release and the
information incorporated herein by reference may constitute
“forward-looking statements” for purposes of the federal securities
laws concerning WaveDancer, Firefly, the Merger, and other matters.
These forward-looking statements include express or implied
statements relating to WaveDancer’s and Firefly’s management teams’
expectations, hopes, beliefs, intentions, or strategies regarding
the future. In addition, any statements that refer to projections,
forecasts or other characterizations of future events or
circumstances, including any underlying assumptions, are
forward-looking statements. The words “anticipate,” “believe,”
“contemplate,” “continue,” “could,” “estimate,” “expect,”
“intends,” “may,” “might,” “plan,” “possible,” “potential,”
“predict,” “project,” “should,” “will,” “would” and similar
expressions may identify forward-looking statements, but the
absence of these words does not mean that a statement is not
forward-looking. These forward-looking statements are based on
current expectations and beliefs concerning future developments and
their potential effects. There can be no assurance that future
developments affecting WaveDancer, Firefly or the Merger will be
those that have been anticipated. These forward-looking statements
involve a number of risks, uncertainties (some of which are beyond
WaveDancer’s or Firefly’s control) or other assumptions that may
cause actual results or performance to be materially different from
those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to, the
risk that the conditions to the closing of the Merger are not
satisfied, including the failure to obtain stockholder approval for
the transaction; uncertainties as to the timing of the consummation
of the Merger and the ability of each of WaveDancer and Firefly to
consummate the Merger; risks related to WaveDancer’s continued
listing on the Nasdaq Stock Market until closing of the Merger;
risks related to WaveDancer’s and Firefly’s ability to correctly
estimate their respective operating expenses and expenses
associated with the Merger, as well as uncertainties regarding the
impact any delay in the closing would have on the anticipated cash
resources of the combined company upon closing and other events and
unanticipated spending and costs that could reduce the combined
company’s cash resources; the occurrence of any event, change or
other circumstance or condition that could give rise to the
termination of the Merger Agreement; the effect of the announcement
or pendency of the Merger on WaveDancer’s or Firefly’s business
relationships, operating results and business generally; costs
related to the Merger; the outcome of any legal proceedings that
may be instituted against WaveDancer, Firefly or any of their
respective directors or officers related to the Merger Agreement or
the Mergers contemplated thereby; the ability of WaveDancer or
Firefly to protect their respective intellectual property rights;
competitive responses to the Merger; unexpected costs, charges or
expenses resulting from the Merger; potential adverse reactions or
changes to business relationships resulting from the announcement
or completion of the Merger; legislative, regulatory, political and
economic developments; and those factors described under the
heading “Risk Factors” in the WaveDancer’s most recent Annual
Report on Form 10-K filed with the Securities and Exchange
Commission (“SEC”), as well as discussions of potential risks,
uncertainties, and other important factors included in later
filings, including any Quarterly Reports on Form 10-Q and Current
Reports on Form 8-K, and those factors included under the heading
“Risk Factors” in the registration statement on Form S-4 filed by
WaveDancer with the SEC, as amended. Should one or more of these
risks or uncertainties materialize, or should any of WaveDancer’s
assumptions prove incorrect, actual results may vary in material
respects from those projected in these forward-looking statements.
It is not possible to predict or identify all such risks.
Forward-looking statements included in this press release only
speak as of the date they are made, and neither WaveDancer nor
Firefly undertakes any obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities laws.
Investor ContactKCSA Strategic
CommunicationsValter Pinto, Managing DirectorPH: (212)
896-1254Valter@KCSA.com
Grafico Azioni WaveDancer (NASDAQ:WAVD)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni WaveDancer (NASDAQ:WAVD)
Storico
Da Dic 2023 a Dic 2024